@article{fccb96ee94b74e2ca2e7bd6a0ee5ac63,
title = "Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death",
keywords = "allogeneic transplant, cytarabine, mantle cell lymphoma, prognosis, refractory",
author = "{for the Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network} and Carlo Visco and Tisi, {Maria C.} and Andrea Evangelista and {Di Rocco}, Alice and Zoellner, {Anna Katharina} and Zilioli, {Vittorio R.} and Stefan Hohaus and Roberta Sciarra and Alessandro Re and Cristina Tecchio and Annalisa Chiappella and Lucia Morello and Guido Gini and Luca Nassi and Tommasina Perrone and Molinari, {Anna L.} and Alberto Fabbri and Cox, {Maria C.} and Erica Finolezzi and Simone Ferrero and Benedetta Puccini and {Alvarez De Celis}, Isabel and Annalisa Arcari and Dario Marino and Michele Merli and Francesco Piazza and Massimo Gentile and Matteo Pelosini and Giacomo Loseto and Olivier Hermine and Martin Dreyling and Marco Ruggeri and Maurizio Martelli and Eva Hoster and Umberto Vitolo",
year = "2018",
month = jan,
day = "1",
doi = "10.1111/bjh.15643",
language = "English",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
}